Burden of disease from cryptosporidiosis

Current Opinion in Infectious Diseases

Volumn 25, Issue 5, 2012, Pages 555-563

  Shirley, Debbie Ann T ^a   Moonah, Shannon N ^b   Kotloff, Karen L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cryptosporidiosis; diarrhea; HIV; malnutrition; review

Indexed keywords

NITAZOXANIDE; PAROMOMYCIN; PLACEBO; VACCINE;

CLINICAL FEATURE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DIARRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOTHERAPY; INCIDENCE; MALNUTRITION; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; VACCINATION;

ANTIGENS, PROTOZOAN; ANTIPARASITIC AGENTS; COST OF ILLNESS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; WORLD HEALTH;

EID: 84865861472     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328357e569     Document Type: Review

References (102)

1. Navin TR, Juranek DD. Cryptosporidiosis: clinical, epidemiologic, and parasitologic review. Rev Infect Dis 1984; 6:313-327.
2. Chappell CL, Okhuysen PC, Langer-Curry RC, et al. Cryptosporidium meleagridis: infectivity in healthy adult volunteers. Am J Trop Med Hyg 2011; 85:238-242.
3. Robinson G, Elwin K, Chalmers RM. Unusual Cryptosporidium genotypes in human cases of diarrhea. Emerg Infect Dis 2008; 14:1800-1802.
4. Xiao L. Molecular epidemiology of cryptosporidiosis: an update. Exp Parasitol 2010; 124:80-89.
5. O'Connor RM, Shaffie R, Kang G, Ward HD. Cryptosporidiosis in patients with HIV/AIDS. AIDS 2011; 25:549-560.
6. Morse TD, Nichols RA, Grimason AM, et al. Incidence of cryptosporidiosis species in paediatric patients in Malawi. Epidemiol Infect 2007; 135:1307-1315.
7. Gatei W, Barrett D, Lindo JF, et al. Unique Cryptosporidium population in HIV-infected persons. Jamaica Emerg Infect Dis 2008; 14:841-843.
8. Iqbal A, Lim YA, Surin J, Sim BL. High diversity of Cryptosporidium subgenotypes identified in Malaysian HIV/AIDS individuals targeting gp60 gene. PLoS One 2012; 7:e31139.
9. Muthusamy D, Rao SS, Ramani S, et al. Multilocus genotyping of Cryptosporidium sp. isolates from human immunodeficiency virus-infected individuals in South India. J Clin Microbiol 2006; 44:632-634.
10. Cama VA, Ross JM, Crawford S, et al. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis 2007; 196:684-691.
11. Hira KG, Mackay MR, Hempstead AD, et al. Genetic diversity of Cryptosporidium spp. from Bangladeshi children. J Clin Microbiol 2011; 49:2307-2310.
12. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991; 4:325-358.
13. Chappell CL, Okhuysen PC, Sterling CR, DuPont HL. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 1996; 173:232-236.
14. Jokipii L, Jokipii AM. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med 1986; 315:1643-1647.
15. DuPont HL, Chappell CL, Sterling CR, et al. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995; 332:855-859.
16. Okhuysen PC, Chappell CL, Crabb JH, et al. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis 1999; 180:1275-1281.
17. Chappell CL, Okhuysen PC, Langer-Curry R, et al. Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 2006; 75: 851-857.
18. Yoder JS, Harral C, Beach MJ. Cryptosporidiosis surveillance: United States, 2006-2008. MMWR Surveill Summ 2010; 59:1-14.
19. Rolfs RT, Beach MJ, Hlavsa MC, et al. Communitywide cryptosporidiosis outbreak-Utah, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:989-993.
20. Chappell CL, Okhuysen PC, Sterling CR, et al. Infectivity of Cryptosporidium parvum in healthy adults with preexisting anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg 1999; 60:157-164.
21. Heijbel H, Slaine K, Seigel B, et al. Outbreak of diarrhea in a day care center with spread to household members: the role of Cryptosporidium. Pediatr Infect Dis J 1987; 6:532-535.
22. Sorvillo FJ, Lieb LE, Kerndt PR, Ash LR. Epidemiology of cryptosporidiosis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 1994; 51:326-331.
23. Vandenberg O, Robberecht F, Dauby N, et al. Management of a Cryptosporidium hominis outbreak in a day-care center. Pediatr Infect Dis J 2012; 31:10-15.
24. Steinberg EB, Mendoza CE, Glass R, et al. Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg 2004; 70:83-88.
25. Valentiner-Branth P, Steinsland H, Fischer TK, et al. Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol 2003; 41:4238-4245.
26. Bilenko N, Ghosh R, Levy A, et al. Partial breastfeeding protects Bedouin infants from infection and morbidity: prospective cohort study. Asia Pac J Clin Nutr 2008; 17:243-249.
27. Siwila J, Phiri IG, Enemark HL, et al. Intestinal helminths and protozoa in children in preschools in Kafue district, Zambia. Trans R Soc Trop Med Hyg 2010; 104:122-128.
28. Cama VA, Bern C, Roberts J, et al. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis 2008; 14: 1567-1574.
29. Ochoa TJ, Salazar-Lindo E, Cleary TG. Management of children with infection-associated persistent diarrhea. Semin Pediatr Infect Dis 2004; 15:229-236.
30. Mondal D, Haque R, Sack RB, et al. Attribution of malnutrition to causespecific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg 2009; 80:824-826.
31. Agnew DG, Lima AA, Newman RD, et al. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis 1998; 177:754-760.
32. Checkley W, Epstein LD, Gilman RH, et al. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol 1998; 148:497-506.
33. Molbak K, Andersen M, Aaby P, et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr 1997; 65:149-152.
34. Moore SR, Lima NL, Soares AM, et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 2010; 139:1156-1164.
35. Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr 2001; 32:550-554.
36. Haque R, Mondal D, Karim A, et al. Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh. Clin Infect Dis 2009; 48:1191-1197.
37. Mondal D, Minak J, Alam M, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2012; 54:185-192.
38. Guerrant DI, Moore SR, Lima AA, et al. Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999; 61:707-713.
39. Mor SM, Tzipori S. Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge. Clin Infect Dis 2008; 47:915-921.
40. Tumwine JK, Kekitiinwa A, Nabukeera N, et al. Cryptosporidium parvum in children with diarrhea in Mulago Hospital, Kampala, Uganda. Am J Trop Med Hyg 2003; 68:710-715.
41. Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis 2010; 23:494-499.
42. Bern C, Kawai V, Vargas D, et al. The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis 2005; 191:1658-1664.
43. Brady MT, Oleske JM, Williams PL, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 2010; 53:86-94.
44. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30 (Suppl 1): S5-S14.
45. United Nations. http://unstats.un.org/unsd/mdg/Resources/Static/Products/ Progress2011/11-31339%20(E)%20MDG%20Report%202011-Book% 20LR.pdf. New York: United Nations; 2011. [Accessed 17 May 2011]
46. Denkinger CM, Harigopal P, Ruiz P, Dowdy LM. Cryptosporidium parvumassociated sclerosing cholangitis in a liver transplant patient. Transpl Infect Dis 2008; 10:133-136.
47. Mor SM, Tumwine JK, Ndeezi G, et al. Respiratory cryptosporidiosis in HIVseronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis 2010; 50:1366-1372.
48. Bushen OY, Kohli A, Pinkerton RC, et al. Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum. Trans R Soc Trop Med Hyg 2007; 101: 378-384.
49. Hunter PR, Hughes S, Woodhouse S, et al. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis 2004; 39:504-510.
50. Del Chierico F, Onori M, Di Bella S, et al. Cases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples. Ann Trop Med Parasitol 2011; 105:339-349.
51. Kaushik K, Khurana S, Wanchu A, Malla N. Evaluation of staining techniques, antigen detection and nested PCR for the diagnosis of cryptosporidiosis in HIV seropositive and seronegative patients. Acta Trop 2008; 107:1-7.
52. Chalmers RM, Campbell BM, Crouch N, et al. Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J Med Microbiol 2011; 60 (Pt 11):1598-1604.
53. Morgan UM, Pallant L, Dwyer BW, et al. Comparison of PCR and microscopy for detection of Cryptosporidium parvum in human fecal specimens: clinical trial. J Clin Microbiol 1998; 36:995-998.
54. Calderaro A,Montecchini S, Gorrini C, et al. Similar diagnostic performances of antigen detection and nucleic acid detection of Cryptosporidium spp. in a low-prevalence setting. Diagn Microbiol Infect Dis 2011; 70:72-77.
55. Weber R, Bryan RT, Bishop HS, et al. Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991; 29:1323-1327.
56. Polage CR, Stoddard GJ, Rolfs RT, Petti CA. Physician use of parasite tests in the United States from 1997 to 2006 and in a Utah Cryptosporidium outbreak in 2007. J Clin Microbiol 2011; 49:591-596.
57. Miller JR, Mojica B, Nadle J, et al. False-positive laboratory tests for Cryptosporidium involving an enzyme-linked immunosorbent assay: United States, November 1997-March 1998. MMWR Morb Mortal Wkly Rep 1999; 48:4-8.
58. Christy NC, Hencke JD, Escueta-De Cadiz A, et al. Multisite performance evaluation of an enzyme-linked immunosorbent assay for detection of Giardia, Cryptosporidium, and Entamoeba histolytica antigens in human stool. J Clin Microbiol 2012; 50:1762-1763.
59. Taniuchi M, Verweij JJ, Noor Z, et al. High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites. Am J Trop Med Hyg 2011; 84:332-337.
60. Jex AR, Stanley KK, Lo W, et al. Detection of diarrhoeal pathogens in human faeces using an automated, robotic platform. Mol Cell Probes 2012; 26:11-15.
61. Binka E, Vermund SH, Armah GE. Rotavirus diarrhea among children less than 5 years of age in urban Ghana. Pediatr Infect Dis J 2011; 30:716-718.
62. Opintan JA, Newman MJ, Ayeh-Kumi PF, et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg 2010; 83:936-943.
63. Siwila J, Phiri IG, Enemark HL, et al. Seasonal prevalence and incidence of Cryptosporidium spp. and Giardia duodenalis and associated diarrhoea in children attending preschool in Kafue, Zambia. Trans R Soc Trop Med Hyg 2011; 105:102-108.
64. Moyo SJ, Gro N, Matee MI, et al. Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in Dar es Salaam, Tanzania. BMC Pediatr 2011; 11:19.
65. Ranjbar-Bahadori S, Sangsefidi H, Shemshadi B, Kashefinejad M. Cryptosporidiosis and its potential risk factors in children and calves in Babol, north of Iran. Trop Biomed 2011; 28:125-131.
66. Nunez FA, Gonzalez OM, Gonzalez I, et al. Intestinal coccidia in Cuban pediatric patients with diarrhea. Mem Inst Oswaldo Cruz 2003; 98:539-542.
67. Carvalho-Costa FA, Goncalves AQ, Lassance SL, et al. Detection of Cryptosporidium spp. and other intestinal parasites in children with acute diarrhea and severe dehydration in Rio de Janeiro. Rev Soc Bras Med Trop 2007; 40:346-348.
68. Gay-Andrieu E, Adehossi E, Illa H, et al. Prevalence of cryptosporidiosis in pediatric hospital patients in Niamey, Niger. Bull Soc Pathol Exot 2007; 100:193-196.
69. Mukhopadhyay C, Wilson G, Pradhan D, Shivananda PG. Intestinal protozoal infestation profile in persistent diarrhea in children below age 5 years in western Nepal. Southeast Asian J Trop Med Public Health 2007; 38:13-19.
70. McDonald AC, Mac Kenzie WR, Addiss DG, et al. Cryptosporidium parvumspecific antibody responses among children residing in Milwaukee during the 1993 waterborne outbreak. J Infect Dis 2001; 183:1373-1379.
71. Collinet-Adler S, Ward HD. Cryptosporidiosis: environmental, therapeutic, and preventive challenges. Eur J Clin Microbiol Infect Dis 2010; 29:927-935.
72. Kuhls TL, Mosier DA, Crawford DL, Griffis J. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis 1994; 18:731-735.
73. Robin G, Fraser D, Orr N, et al. Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination. Am J Epidemiol 2001; 153:194-201.
74. Leach CT, Koo FC, Kuhls TL, et al. Prevalence of Cryptosporidium parvum infection in children along the Texas-Mexico border and associated risk factors. Am J Trop Med Hyg 2000; 62:656-661.
75. Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, et al. Cryptosporidiosis and microsporidiosis in Ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hyg 2005; 73:921-925.
76. Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 2002; 15:145-154.
77. Ramakrishnan K, Shenbagarathai R, Uma A, et al. Prevalence of intestinal parasitic infestation in HIV/AIDS patients with diarrhea in Madurai City, South India. Jpn J Infect Dis 2007; 60:209-210.
78. Ojurongbe O, Raji OA, Akindele AA, et al. Cryptosporidium and other enteric parasitic infections in HIV-seropositive individuals with and without diarrhoea in Osogbo, Nigeria. Br J Biomed Sci 2011; 68:75-78.
79. Dwivedi KK, Prasad G, Saini S, et al. Enteric opportunistic parasites among HIV infected individuals: associated risk factors and immune status. Jpn J Infect Dis 2007; 60:76-81.
80. Alemu A, Shiferaw Y, Getnet G, et al. Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, North West Ethiopia. Asian Pac J Trop Med 2011; 4:661-665.
81. Srisuphanunt M, Saksirisampant W, Karanis P. Prevalence and genotyping of Cryptosporidium isolated from HIV/AIDS patients in urban areas of Thailand. Ann Trop Med Parasitol 2011; 105:463-468.
82. Kong BN, Harwell JI, Suos P, et al. Opportunistic infections and HIV clinical disease stage among patients presenting for care in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health 2007; 38:62-68.
83. Asma I, Johari S, Sim BL, Lim YA. How common is intestinal parasitism in HIVinfected patients in Malaysia? Trop Biomed 2011; 28:400-410.
84. Erhabor O, Obunge O, Awah I. Cryptosporidiosis among HIV-infected persons in the Niger Delta of Nigeria. Niger J Med 2011; 20:372-375.
85. Kurniawan A, Karyadi T, Dwintasari SW, et al. Intestinal parasitic infections in HIV/AIDS patients presenting with diarrhoea in Jakarta, Indonesia. Trans R Soc Trop Med Hyg 2009; 103:892-898.
86. Vignesh R, Balakrishnan P, Shankar EM, et al. High proportion of isosporiasis among HIV-infected patients with diarrhea in southern India. Am J Trop Med Hyg 2007; 77:823-824.
87. Bresee JS, Marcus R, Venezia RA, et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis 2012; 205:1374-1381.
88. Kotloff KL, Wasserman SS, Steciak JY, et al. Acute diarrhea in Baltimore children attending an outpatient clinic. Pediatr Infect Dis J 1988; 7:753-759.
89. Corso PS, Kramer MH, Blair KA, et al. Cost of illness in the 1993 waterborne Cryptosporidium outbreak, Milwaukee, Wisconsin. Emerg Infect Dis 2003; 9:426-431.
90. Hlavsa MC, Roberts VA, Anderson AR, et al. Surveillance for waterborne disease outbreaks and other health events associated with recreational water: United States, 2007-2008. MMWR Surveill Summ 2011; 60:1-32.
91. Baldursson S, Karanis P. Waterborne transmission of protozoan parasites: review of worldwide outbreaks-an update 2004-2010. Water Res 2011; 45:6603-6614.
92. Desoubeaux G, Caumont C, Passot C, et al. Two cases of opportunistic parasite infections in patients receiving alemtuzumab. J Clin Pathol 2012; 65:92-95.
93. Bonatti H, Barroso Ii LF, Sawyer RG, et al. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations. Transpl Infect Dis 2012. [Epub ahead of print]
94. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 2001; 184:103-106.
95. Gargala G, Le Goff L, Ballet JJ, et al. Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum. Antimicrob Agents Chemother 2010; 54:1315-1318.
96. Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis 2009; 9:195.
97. Rossignol JF, Lopez-Chegne N, Julcamoro LM, et al. Nitazoxanide for the empiric treatment of pediatric infectious diarrhea. Trans R Soc Trop Med Hyg 2012; 106:167-173.
98. McDonald V. Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies. Expert Rev Anti Infect Ther 2011; 9:1077-1086.
99. Boulter-Bitzer JI, Lee H, Trevors JT. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Biotechnol Adv 2007; 25:13-44.
100. Borad AJ, Allison GM, Wang D, et al. Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh. Am J Trop Med Hyg 2012; 86:214-222.
101. Mead JR. Challenges and prospects for a Cryptosporidium vaccine. Future Microbiol 2010; 5:335-337.
102. Costa LB, Noronha FJ, Roche JK, et al. Novel in vitro and in vivo models and potential new therapeutics to break the vicious cycle of Cryptosporidium infection and malnutrition. J Infect Dis 2012; 205:1464-1471.